InfuSystem Announces $20 Million Stock Repurchase Program

Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) announced a new stock repurchase program to buy back up to $20 million of its common stock through June 30, 2024. This program replaces the prior authorization that expired on December 31, 2020, and is intended to enhance shareholder value. CEO Richard DiIorio expressed confidence in the company's operations and future growth prospects, emphasizing the program's role in strategic capital allocation.

Positive

• Approval of a $20 million stock buyback program enhances shareholder value.
• Management expresses strong confidence in the company's operational stability and growth outlook.

Negative

• None.

ROCHESTER HILLS, Michigan, June 30, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Company’s Board of Directors has approved a stock repurchase program authorizing the Company to repurchase up to $20 million of the Company’s outstanding common stock through June 30, 2024. Repurchases will be made through open market purchases, private transactions, or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 under the Securities Exchange Act of 1934 (the “Exchange Act”).

Richard DiIorio, Chief Executive Officer of InfuSystem, said, “This authorization will replace the prior authorization which expired on December 31, 2020 and will provide us with an additional capital allocation option to enhance shareholder value. Additionally, the stock repurchase program emphasizes the confidence that management has in the Company’s solid operations, strength of our balance sheet and the outlook for strong growth in 2022 and beyond. Our top priority for use of capital remains making strategic investments that position the Company for sustainable growth, although this program provides us with the flexibility to be opportunistic in repurchasing shares when valuations become attractive.”

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Integrated Therapy Services (“ITS”), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, and Wound Therapy businesses. The second platform, Durable Medical Equipment Services (“DME Services”), supports the ITS platform and leverages strong service orientation to win incremental business from its direct payer clients. The DME Services segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.  Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.

Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, our share repurchase program and capital allocation strategy, business plans, objectives and prospects, future operating or financial performance and guidance. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “strategy,” “future,” “likely,” variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. Forward-looking statements are subject to factors, risks and uncertainties that could cause actual results to differ materially, including, but not limited to, the uncertain impact of the COVID-19 pandemic or our dependence on estimates of collectible revenue, potential litigation, changes in third-party reimbursement processes, changes in law, contributions from acquired businesses or new business lines, products or services and other risk factors disclosed in the Company’s most recent annual report on Form 10-K and, to the extent applicable, quarterly reports on Form 10-Q. All forward-looking statements made in this press release speak only as of the date hereof. We do not undertake any obligation to update any forward-looking statements to reflect future events or circumstances, except as required by law.

Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.

####

FAQ

What is the purpose of the INFU stock repurchase program?

The INFU stock repurchase program aims to enhance shareholder value by allowing the company to buy back up to $20 million of its outstanding common stock.

When does the INFU stock buyback program expire?

The INFU stock buyback program is authorized through June 30, 2024.

How much capital is allocated for the INFU stock repurchase?

InfuSystem has authorized up to $20 million for the stock repurchase program.

What does the INFU management say about its future growth?

Management emphasizes confidence in the company's solid operations and a strong outlook for growth in 2022 and beyond.